-
Failure Mode and Effects Analysis (FMEA) for Experimental Use of FLASH on a Clinical Accelerator
Authors:
Mahbubur Rahman,
Rongxiao Zhang,
David J. Gladstone,
Benjamin B. Williams,
Erli Chen,
Chad A. Dexter,
Lawrence Thompson,
Petr Bruza,
Brian W. Pogue
Abstract:
Background: Use of a linear accelerator in ultra-high dose rate (UHDR) mode can provide a conduit for wider access to UHDR FLASH effects, sparing normal tissue, but care needs to be taken in the use of such systems to ensure errors are minimized.
Purpose: Failure Modes and Effects Analysis (FMEA) was carried out in a team that has been involved in converting a LINAC between clinical use and UHDR…
▽ More
Background: Use of a linear accelerator in ultra-high dose rate (UHDR) mode can provide a conduit for wider access to UHDR FLASH effects, sparing normal tissue, but care needs to be taken in the use of such systems to ensure errors are minimized.
Purpose: Failure Modes and Effects Analysis (FMEA) was carried out in a team that has been involved in converting a LINAC between clinical use and UHDR experimental mode for more than one year, following the proposed methods of TG100.
Methods: A team of 9 professionals with extensive experience were polled to outline the process map and workflow for analysis, and developed fault trees for potential errors, as well as failure modes that would results. The team scored the categories of severity magnitude (S), occurrence likelihood (O), and detectability potential (D) in a scale of 1 to 10, so that a risk priority number (RPN=S*O*D) could be assessed for each.
Results: A total of 46 potential failure modes were identified, including 5 with RPN>100. These failure modes involved 1) patient set up, 2) gating mechanisms in delivery, and 3) detector in the beam stop mechanism. Identified methods to mitigate errors included 1) use of a checklist post conversion, 2) use of robust radiation detectors, 3) automation of QA and beam consistency checks, and 4) implementation of surface guidance during beam delivery.
Conclusions: The FMEA process was considered critically important in this setting of a new use of a LINAC, and the expert team developed a higher level of confidence in the ability to safely move UHDR LINAC use towards expanded research access.
△ Less
Submitted 20 December, 2021;
originally announced December 2021.
-
Individual Pulse Monitoring and Dose Control System for Pre-Clinical Implementation of FLASH-RT
Authors:
M. Ramish Ashraf,
Mahbubur Rahman,
Xu Cao,
Kayla Duval,
Benjamin B. Williams,
P. Jack Hoopes,
David J. Gladstone,
Brian W. Pogue,
Rongxiao Zhang,
Petr Bruza
Abstract:
Ultra-high dose rate electron sources require dose rate independent dosimeters and a calibrated dose control system for accurate delivery. In this study, we developed a single-pulse dose monitoring and a real-time dose-based control system for a converted clinical linear accelerator (LINAC). A point scintillator detector was coupled to a gated amplifier and a real-time controller for dose monitori…
▽ More
Ultra-high dose rate electron sources require dose rate independent dosimeters and a calibrated dose control system for accurate delivery. In this study, we developed a single-pulse dose monitoring and a real-time dose-based control system for a converted clinical linear accelerator (LINAC). A point scintillator detector was coupled to a gated amplifier and a real-time controller for dose monitoring and feedback control loop. The controller was programmed to integrate dose and measure pulse width of each radiation pulse and gate the LINAC beam when the prescribed dose was delivered. The scintillator was mounted in solid water phantom and placed underneath mice skin for in vivo dose monitoring. Additionally, the scintillator was characterized in terms of its radiation stability, mean dose-rate, and dose per pulse dependence. Dose integration was performed for each radiation pulse and displayed in real-time. The scintillator was shown to be linear with mean dose-rate (40-380 Gy/s) and dose per pulse (0.3-1.3 Gy/Pulse) to within +/- 3%. However, the plastic scintillator was subject to significant radiation damage (16%/kGy) and would need to be calibrated frequently. Pulse-counting control was accurately implemented with direct correspondence between the intended and the actual delivered pulses. The dose-based control was sufficient to gate on any pulse of the LINAC. In-vivo dosimetry monitoring with a 1 cm circular cut-out revealed that a ramp-up of 4-5 pulses was present during which the average dose per pulse was ~0.045 +/- 0.004 Gy/Pulse, whereas after the ramp-up it stabilized at 0.65 +/- 0.01 Gy/Pulse. The tools presented in this study can be used to determine the beam parameter space pertinent to the FLASH effect. Additionally, this study is the first instance of real-time dose-based control for a modified LINAC at ultra-high dose rates.
△ Less
Submitted 16 November, 2021;
originally announced November 2021.
-
Retrospective Evaluation of an Always-on Cherenkov Imaging System for Radiotherapy Quality Improvement
Authors:
Daniel A. Alexander,
Michael Jermyn,
Petr Bruza,
Rongxiao Zhang,
Erli Chen,
Savannah M. Decker,
Tatum L. McGlynn,
Rory A. Rosselot,
Jae Lee,
Melanie L. Rose,
Benjamin B. Williams,
Brian W. Pogue,
David J. Gladstone,
Lesley A. Jarvis
Abstract:
Purpose: Cherenkov imaging is now clinically available to track the course of radiation therapy as a treatment verification tool. The aim of this work was to discover the benefits of always-on Cherenkov images as a novel incident detection and quality improvement system through retrospective review of imaging in our center.
Methods: Continuous imaging of all patients was attempted during a 12-mo…
▽ More
Purpose: Cherenkov imaging is now clinically available to track the course of radiation therapy as a treatment verification tool. The aim of this work was to discover the benefits of always-on Cherenkov images as a novel incident detection and quality improvement system through retrospective review of imaging in our center.
Methods: Continuous imaging of all patients was attempted during a 12-month period by automating the acquisition of Cherenkov imaging using an always-on commercial system. Multi-camera systems were installed in two treatment bunkers in the radiation oncology clinic at our center and one bunker in an affiliated satellite clinic. Images were acquired as part of normal treatment procedure and reviewed retrospectively with potential incidents flagged for evaluation by the physician and medical physics teams.
Results: In total, 622 patients were imaged as part of this study. In this summary, 9 patients were identified with incidents occurring during their course of treatment that were detected only with Cherenkov imaging. Incidents were found relating to issues during simulation, planning, pre-treatment review, and treatment delivery, however none of the incidents were detected prior to treatment delivery. Primary areas of improvement identified in this study are dose to unintended areas in planning, dose to unintended areas due to positioning, and non-ideal bolus placement during setup. Case studies are presented highlighting the detection of these issues using Cherenkov imaging.
Conclusions: All detected events were deemed below the threshold for reporting, but their observation could lead to quality improvement in practice. Perhaps most importantly, the imaging was seamless with no effort required by the radiotherapy team and provided both real-time and permanent records of what was delivered in each fraction.
△ Less
Submitted 14 October, 2021;
originally announced October 2021.
-
Electron FLASH Delivery at Treatment Room Isocenter for Efficient Reversible Conversion of a Clinical LINAC
Authors:
Mahbubur Rahman,
M. Ramish Ashraf,
Rongxiao Zhang,
Petr Bruza,
Chad A. Dexter,
Lawrence Thompson,
Xu Cao,
Benjamin B. Williams,
P. Jack Hoopes,
Brian W. Pogue,
David J. Gladstone
Abstract:
Purpose: In this study, procedures were developed to achieve efficient reversible conversion of a clinical linear accelerator (LINAC) and deliver electron FLASH (eFLASH) or conventional beams to the treatment room isocenter. Material & Methods: The LINAC was converted to deliver eFLASH beam within 20 minutes by retracting the x-ray target from the beam's path, positioning the carousel on an empty…
▽ More
Purpose: In this study, procedures were developed to achieve efficient reversible conversion of a clinical linear accelerator (LINAC) and deliver electron FLASH (eFLASH) or conventional beams to the treatment room isocenter. Material & Methods: The LINAC was converted to deliver eFLASH beam within 20 minutes by retracting the x-ray target from the beam's path, positioning the carousel on an empty port, and selecting 10 MV photon beam energy in the treatment console. Dose per pulse and average dose rate were measured in a solid water phantom at different depths with Gafchromic film and OSLD. A pulse controller counted the pulses via scattered radiation signal and gated the delivery for preset pulse count. A fast photomultiplier tube-based Cherenkov detector measured per pulse beam output at 2 ns sampling rate. After conversion back to clinical mode, conventional beam output, flatness, symmetry, field size and energy were measured for all clinically commissioned energies. Results: Dose per pulse of 0.86 +/- 0.01 Gy (310 +/- 7 Gy/s average dose rate) were achieved at isocenter. The dose from simultaneous irradiation of film and OSLD were within 1%. The PMT showed the LINAC required about 5 pulses before the output stabilized and its long-term stability was within 3% for measurements performed at 3 minutes intervals. The dose, flatness, symmetry, and photon energy were unchanged from baseline and within tolerance (1%, 3%, 2%, and 0.1% respectively) after reverting to conventional beams. Conclusion: 10 MeV FLASH beams were achieved at the isocenter of the treatment room. The beam output was reproducible but requires further investigation of the ramp up time in the first 5 pulses, equivalent to <100 cGy. The eFLASH beam can irradiate both small and large subjects in minimally modified clinical settings and dose rates can be further increased by reducing the source to surface distance.
△ Less
Submitted 1 February, 2021; v1 submitted 16 August, 2020;
originally announced August 2020.
-
Dosimetry for FLASH Radiotherapy: A Review of Tools and the Role of Radioluminescence and Cherenkov Emission
Authors:
Muhammad Ramish Ashraf,
Mahbubur Rahman,
Rongxiao Zhang,
Benjamin B. Williams,
David J. Gladstone,
Brian W. Pogue,
Petr Bruza
Abstract:
While spatial dose conformity delivered to a target volume has been pushed to its practical limits with advanced treatment planning and delivery, investigations in novel temporal dose delivery are unfolding new mechanisms. Recent advances in ultra-high dose radiotherapy, abbreviated as FLASH, indicate the potential for reduction in healthy tissue damage while preserving tumor control. FLASH therap…
▽ More
While spatial dose conformity delivered to a target volume has been pushed to its practical limits with advanced treatment planning and delivery, investigations in novel temporal dose delivery are unfolding new mechanisms. Recent advances in ultra-high dose radiotherapy, abbreviated as FLASH, indicate the potential for reduction in healthy tissue damage while preserving tumor control. FLASH therapy relies on very high dose rate of > 40Gy/sec with sub-second temporal beam modulation, taking a seemingly opposite direction from the conventional paradigm of fractionated therapy. FLASH brings unique challenges to dosimetry, beam control, and verification, as well as complexity of radiobiological effective dose through altered tissue response. In this review, we compare the dosimetric methods capable of operating under high dose rate environments. Due to excellent dose-rate independence, superior spatial (~<1 mm) and temporal (~ns) resolution achievable with Cherenkov and scintillation-based detectors, we show that luminescent detectors have a key role to play in the development of FLASH-RT, as the field rapidly progresses towards clinical adaptation. Additionally, we show that the unique ability of certain luminescence-based methods to provide tumor oxygenation maps in real-time with submillimeter resolution can elucidate the radiobiological mechanisms behind the FLASH effect. In particular, such techniques will be crucial for understanding the role of oxygen in mediating the FLASH effect.
△ Less
Submitted 17 June, 2020; v1 submitted 5 June, 2020;
originally announced June 2020.
